To monitor p53 levels, we used a well‐characterized clonal MCF7 breast carcinoma cell line that expresses a p53‐Venus yellow fluorescent protein fusion in addition to, but at a lower concentration than, endogenously expressed wild‐type p53 (Loewer et al, 2010). The gene discussed is TP53; the disease is breast carcinoma.